Investigating a protein linked to blood clotting and pregnancy complications
Structural Studies of Beta-2 glycoprotein I in the Antiphospholipid Syndrome
This study is looking at a protein called beta-2 glycoprotein I to learn more about how it affects people with Antiphospholipid Syndrome, which can cause serious blood clots and pregnancy issues, so we can find better ways to diagnose and treat this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Saint Louis University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10762475 on NIH RePORTER |
What this research studies
This research focuses on Beta-2 glycoprotein I (b2GPI), a protein that plays a crucial role in the autoimmune disorder Antiphospholipid Syndrome (APS). Patients with APS often experience dangerous blood clots and complications during pregnancy. The study aims to better understand the different types of anti-b2GPI antibodies and their effects, which could lead to improved diagnostic tests and treatment options. By analyzing the structure of b2GPI, researchers hope to identify patients at higher risk for thrombosis and develop more effective therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Antiphospholipid Syndrome or those experiencing recurrent pregnancy complications related to blood clotting.
Not a fit: Patients without a diagnosis of Antiphospholipid Syndrome or those not experiencing related complications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better diagnosis and treatment options for patients with Antiphospholipid Syndrome, potentially reducing the risk of blood clots and pregnancy complications.
How similar studies have performed: Previous research has shown promise in understanding the role of b2GPI in APS, but this specific approach to studying its structure and implications is relatively novel.
Where this research is happening
Saint Louis, United States
- Saint Louis University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Pozzi, Nicola — Saint Louis University
- Study coordinator: Pozzi, Nicola
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.